His experience includes the preparation of new patent and plant variety applications; patentability, validity, and freedom-to-operate opinions; licensing agreements; investigations into inventorship and third-party rights; and patent portfolio design and management.Prior to his legal career, David Kuttenkeuler studied molecular biology, biochemistry, and cell biology at the University of Regensburg and the University of Heidelberg in Germany. During his PhD he developed high-throughput RNA interference screens to identify novel components of the immune signaling cascade at the German Cancer Research Center in Heidelberg. After graduating, David Kuttenkeuler worked as a postdoctoral research fellow at the Wellcome Trust Sanger Institute in Cambridge, UK, focusing his interest on combined RNA interference and population genetic approaches to unravel genetic interaction networks in higher multi-cellular organisms. His research is published in numerous high impact journals.David Kuttenkeuler works at BOEHMERT & BOEHMERT since 2008. He is a German and European patent attorney and entitled to represent clients before the German Patent and Trade Mark Office, the European Patent Office (EPO), the Community Plant Variety Office (CPVO), and the European Union Intellectual Property Office (EUIPO).In the past, Dr. Kuttenkeuler has held seminars and presentations at international patent law conferences about various biotech relevant topics.David Kuttenkeuler is a member of the German Patent Lawyer Association (Patentanwaltskammer), the Institute of Professional Representatives before the European Patent Office (EPI), the German Association of Intellectual Property and Copyright (GRUR), Licensing Executives Society (LES), and the German Association for Biochemistry and Molecular Biology.